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Abstract
Background—This study investigates how deviated nasal septum affects the quantity and
distribution of spray particles, and examines the effects of inspiratory airflow and head position on
particle transport.
Methods—Deposition of spray particles was analysed using a three-dimensional computational
fluid dynamics model created from a computed tomography scan of a human nose with leftward
septal deviation and a right inferior turbinate hypertrophy. Five simulations were conducted using
Fluent™ software, with particle sizes ranging from 20-110μm, a spray speed of 3m/s, plume angle
of 68°, and with steady state inspiratory airflow either present (15.7L/min) or absent at varying
head positions.
Results—With inspiratory airflow present, posterior deposition on the obstructed side was
approximately four times less than the contralateral side, regardless of head position, and was
statistically significant (p<0.05). When airflow was absent, predicted deposition beyond the nasal
valve on the left and right sides were between 16% and 69% lower and positively influenced by a
dependent head position.
Conclusions—Simulations predicted that septal deviation significantly diminished drug
delivery on the obstructed side. Furthermore, increased particle penetration was associated with
presence of nasal airflow. Head position is an important factor in particle deposition patterns when
inspiratory airflow is absent.
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Intranasal medications such as topical intranasal steroids (INS) or intranasal antihistamines
are widely used to treat a variety of sinonasal inflammatory, allergic, and infectious
disorders. In addition, intranasal drug delivery can be used for systemically acting drugs that
are difficult to deliver through routes other than injection, such as insulin and vaccines.(1)
However, despite the popularity of aqueous nasal sprays, experimental studies have shown
that many spray devices deposit a significant amount of their drug in the anterior, less
metabolically active regions of the nose.(2-6)
A combination of drug, device, and patient factors can contribute to the efficacy of
intranasal drugs. These include drug formulation characteristics, delivery device design,
delivery technique, site of deposition, nasal anatomy, and underlying sinonasal medical
conditions.(7,8) Nasal anatomy is particularly significant since it is characterized by
variations across individuals. The efficacy of drug delivery using nasal sprays has not been
well described in patients with nasal airway obstruction (NAO) due to anatomic nasal
deformities such as nasal septal deviation. Most studies characterizing intranasal drug
deposition patterns have used subjects with normal sinonasal anatomy.(6,9-12) Additionally,
individual anatomic differences and head position have been shown to affect intranasal drug
deposition.(7) In our previous work,(3) we compared drug delivery penetration past the nasal
valve of aqueous spray pumps and nebulizers in a patient with deviated nasal septum.
However, the presence or absence of inspiratory airflow and head position on topical nasal
medications were not considered in this study.
Anatomic nasal deformities in combination with inspiratory airflow and head position have
the potential to significantly alter intranasal drug delivery and limit the efficacy of these
medications. Computational fluid dynamics (CFD) methods have been shown to render
numerical predictions of airflow patterns and particle trajectories in complex geometries
such as the human respiratory system.(2,3,13-32)
The objective of the present study was to investigate the impact of nasal septal deviation on
spray particle penetration and deposition using CFD techniques and to examine the
influence of inspiratory airflow and head positioning. More specifically, the simulated data
generated were used to test the following null hypotheses:
Hypothesis #1: Spray particle penetrations past the nasal valve for both (obstructed left
and “normal” right) sides of the nasal cavity are equal.
Hypothesis #2: The presence or absence of inspiratory airflow does not improve
efficacy of particle transport within the nasal cavity.
Hypothesis #3: Head position does not impact spray particle deposition beyond the
anterior region of the nose.
MATERIALS AND METHODS
Nasal Model Construction
A three-dimensional (3D) nasal airway model of a 30-year-old Caucasian female subject
(weight, 86.4 kg; height, 164.6 cm) with a moderate to severe broad leftward deviation of
the mid-portion of the septum and a compensatory right inferior turbinate hypertrophy (Fig.
1) was created from a CT scan containing 142 slices, with an increment of 0.625 mm, and a
pixel size of 0.313 mm. The subject provided written informed consent as required and
approved by the Institutional Review Board at Medical College of Wisconsin. The CT scan
files were imported into the medical imaging software Mimics™ 13.1 (Materialise, Inc.,
Plymouth, MI), and a 3D reconstruction of the main nasal airways was constructed from
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which the paranasal sinuses were omitted. The 3D reconstruction was exported from
Mimics™ in STL (stereolithography) file format into the CAD and mesh generating
software package ICEM-CFD™ 12.1 (ANSYS, Canonsburg, PA). Planar nostril and outlet
surfaces as well as regions for tracking particle deposition were constructed as shown in our
previous study.(3) The nasal cavity was separated into the following regions:
• Left and Right Anterior Lateral Wall
• Left and Right Anterior Septum
• Left and Right Middle Lateral Wall
• Left and Right Middle Septum
• Nasopharynx
The anterior regions ranged from the nostrils up to the nasal valve area; the middle regions
covered the turbinates and adjacent nasal septum, and the nasopharynx was defined as
posterior to the turbinates and septum.
Head Positions
Spray particle simulations were carried out using three different head positions (described
below) that have been experimentally studied as well as recommended by most
manufactures of topical INS sprays.(7,11,33)
1. Head is held upright in a neutral position at about 0° to the vertical plane identical;
“head upright position.”
2. Head is tilted back at about 45° to the vertical plane; “head back position.”
3. Head is extended just off the edge of a bed or table at about 90° to the vertical
plane while lying down in a supine position; “Mygind’s position.” This position as
pointed out by Merkus et al.(7) was first described by A. W Proetz in 1926 and then
modified by N. Mygind in 1979.
Numerical simulation of airflow and particle trajectories
In order to solve the equations that govern fluid flow, a computational mesh of the airspaces
was created in ICEM-CFD™ using approximately 4 million graded tetrahedral elements
with a three-layer prism-element boundary. This is consistent with an in house mesh density
study that showed that about 4 million elements will provide mesh independent numerical
results.
For the case when airflow was present, steady-state, laminar inspiratory airflow was
simulated using the CFD software package Fluent™ 12.1.4 (ANSYS, Inc., Canonsburg, PA)
under pressure-driven conditions. Laminar flow is sufficient in this study since we are
simulating resting breathing rate. By simulating at steady-state, this implies that time-
dependent variables were held constant and all derivatives with respect to time were zero.
The boundary conditions specified in Fluent™ to determine the airflow field were identical
to those previously used:(3,14,34)
• A “wall” condition assuming that the walls were stationary with zero air velocity at
the air-wall interface.
• A “pressure-inlet” condition at the nostrils with gauge pressure set to zero.
• A “pressure-outlet” condition at the outlet with gauge pressure set to -25.4 Pa that
generated a target steady-state flow rate of 15.7 L/min. This flow rate was twice the
minute volume (amount of air inhaled in 1 min, defined as tidal volume times
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respiratory rate) as estimated from body weight using gender-specific power law
curves derived by Garcia and colleagues (2009).(19)
These authors concluded that data from the 1994 report of the International Committee on
Radiation Protection (ICRP, 1994) was the best source for variation in minute volume by
age and gender. Using the ICRP data, Garcia and colleagues (2009) derived the following
equations:
where VE = minute volume in liters per minute (L/min), M = body mass in kilograms (kg).
These airflow rates are descriptive of ventilation during sedentary activities such as
watching TV or driving a car.(35) Airflow rates for steady-state inspiration were calculated
by assuming that the duration times of inspiration and expiration were the same, so that the
airflow rate for inspiration alone was twice the minute volume. For the case when airflow
was absent, a similar simulation to the airflow-present case above was conducted in
Fluent™ except that gauge pressure was set to 0 Pa at the outlet.
The spray release was defined to be 0.5cm into the nasal vestibule from the nostril surface
on each side. This 0.5cm distance was the largest of those used previously by Kimbell and
colleagues(2) that fit into the nasal vestibule of this patient. Spray was directed laterally or to
the side, away from the septum and toward the outer portion of the eye as recommended by
Benninger et al.(33) The angle of spray insertion was maintained for each side of the nose
without regard to head position. The particle sizes (20-110μm), and spray plume angle of
68° considered in this study resemble the Pfeiffer spray pump PF-80 used by Cheng and
colleagues.(10) A spray velocity of 3m/s was chosen as within the average velocity range of
most commercially available sprays (1-14.7m/s).(2,36) In addition, the discharge velocity of
flunisolide (though unknown) was estimated to be 370cm/s (3.7m/s).(37) The different head
positions were simulated by setting appropriate x, y, and z components to conform to the
direction of gravitational acceleration.
Particle trajectories were calculated using the Discrete Phase Model in Fluent™, assuming
unit density and spherical particles, using Lagrangian equations of motion for particulate
motion, until particle deposited or exited the nasal airway. Particles that exited the nasal
airways at the outlet via the nasopharynx were categorized as “Escaped.” For particles that
deposited in the nasal cavity, the region in which each particle deposited was tracked. The
“solid cone” injection type was specified in Fluent™ for the particle streams that emanated
from the spray release position, which releases streams at randomly dispersed angles
throughout the spray cone region. To adequately characterize the PF-80 pump in Fluent™,
we used Rosin Rammler Particle Size Distribution (RRPSD) set to range in aerodynamic
diameter from 20 to 110μm with mean diameter of 66.7μm and spread distribution
parameter of 2.95. A total of 1000 particle streams were released from each nostril. Analysis
and visualization of results were conducted using Fluent™ and the post-processing software
package Fieldview™ 12 (Intelligent Light, Lyndhurst, PA).
Statistical Analysis
Spray particle simulations were conducted five times. The number of simulations was
obtained by determining the sample size required to estimate the true population mean of the
number of particles depositing on the various regions of the nasal cavity at a 95%
confidence level so that the sample means of the number of deposited particles would lie
within six particles of the actual population mean, where six is the maximum error (or half
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width) of a 95% confidence interval for hypothesis #1. Statistical power analysis was
conducted to obtain the observed power when n=5 for hypothesis #1. For “head upright” and
“head back” positions, we obtained a power of 1, and a power of 0.55 for the Mygind’s
position.
The mean number of particles depositing on the various regions of the nose when spray was
released into the left (obstructed) or right side of the nasal cavity, in one of three head
positions, and when inspiratory airflow was either present at 15.7L/min or absent was
calculated and tabulated. The simulated data generated were used to test the aforementioned
null hypotheses. The Student’s t-test was used to test hypotheses #1 and #2 since two
independent samples were compared (left and right sides for hypothesis #1; airflow present
and absent for hypothesis #2), while analysis of variance (ANOVA) was used to test
hypothesis #3 because three independent samples representing head positions were
compared. Statistical analyses were carried out using Microsoft Excel™ 2007 (Microsoft
Corp., Redmond,WA) and MATLAB™ version R2010b (Mathworks, Inc., Natick, MA); a
p-value less than 0.05 implied statistical significance.
RESULTS
Simulations predicted that most of the spray particles deposited in the anterior region of the
nose, regardless of nasal side, head position, or airflow presence (Table 1). In addition,
simulated results in Table 1 show the anterior lateral wall had substantially more deposition
than anterior septal wall regardless of nasal side, head position, or airflow presence, with a
somewhat greater effect on the right side. Whereas, the middle region revealed greater
deposition on the septum than on the lateral wall regardless of nasal side or presence of
airflow for the “head upright” and “head back” positions. The Mygind’s position had higher
middle lateral wall deposition in the case when airflow was absent. For both breathing
states, no particles were predicted to deposit in the nasopharynx, and no particles exited the
airway. CFD results in Fig. 2A show that about four times as many particles deposited past
the nasal valve on the right side than on the obstructed (left) side when airflow was present.
Higher posterior deposition was also evident when inspiratory flow was absent (Fig. 2B)
except for the Mygind’s head position.
Results of test of hypothesis #1 (Table 2) demonstrate that there is significant difference in
spray particle deposition past the nasal valve between the obstructed (left) and right sides for
every head position, and whether inspiratory airflow was presence or not. In the “head
upright” position with airflow present, the impact of septal deviation on particle transport
was depicted in Fig. 3; aerosolized particle deposition pattern beyond the anterior lateral
wall was evidently lower on the obstructed side compared to the right side. The presence or
absence of airflow was statistically significant in determining the efficiency of particle
transport within the nasal cavity, regardless of head position and side of nasal passage
(Hypothesis #2; Table 3). In general, inspiratory airflow improved particle transport (Fig. 2),
with the exception of the Mygind’s position where deposition on the obstructed side was
predicted to improve when airflow was absent. Table 4 provides a summary of test of
hypothesis #3. With airflow present, simulation predicted that the effect of head position on
spray particle deposition beyond the anterior region of the nose was not statistically
significant for either side of the nasal passage. However, in the case where airflow was
absent, head position significantly influenced deposition patterns posterior of the nasal
valve.
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Prior research on topical drug deposition has been performed in patients with normal nasal
anatomy; therefore, drug deposition in patients with anatomic abnormalities including septal
deviation has not been well described. Furthermore evidence is lacking on how best to
instruct patients in the use of their nasal sprays to optimize spray penetration and
distribution in the presence of a common anatomic deformity such as a septal deviation, let
alone those with normal sinonasal anatomy. In 2004, the American Academy of
Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) conducted a systematic
review of the literature, but could not determine spray techniques that optimized intranasal
spray efficacy.(33) As pointed out by Aggarwal et al.,(38) the reasons why topical nasal drug
deposition patterns are hard to investigate include individual anatomical differences,
different head positions, and the choice of administrative device (sprays or drops).
The angle at which the simulated sprays were directed on each nasal side was guided by the
recommendations of Benninger et al.(33) However, these guidelines had to be interpreted in
the context of the anatomy of the patient in this study such that the actual angle from the
nostril center to the outer eye, which aimed the spray directly onto the lateral vestibule wall,
was modified slightly to point toward the center of the eye rather than the outer corner. More
significant modifications of this angle in other patients might be necessary to accommodate
more severe or more anterior septal deviations. Further studies are needed to characterize the
quantitative effects of such insertion angle modifications. In addition, our CFD simulations
only accounted for regional particle deposition and did not determine the final destination of
aerosols due to mucociliary transport or “runoff” effects of particles after deposition, two
factors that may contribute to the taste that patients may perceive after sprayed medications
are administered. Also, our simulation results were consistent with reports in the literature
indicating that particle sizes ranging in aerodynamic diameter from 20-110μm were not
easily respirable.(3,4)
Methods used to evaluate nasal deposition of topical medications include endoscopic
visualization of dyed aerosols, CT imaging after application of contrast medium, or
quantification of radioactivity or dye collected on strategically-placed surgical pledgets.
CFD has several advantages over these other methods. First, patients are not exposed to any
additional radiation other than that necessary for diagnostic CT scans. Second, quantitative,
regional deposition patterns are obtained with much greater accuracy than is possible with
other methods. Third, an unlimited number of simulations with varied parameters can be
performed without any additional inconvenience or risk to the patient. A number of CFD
studies of nasal spray deposition have been conducted,(2,13,24-26,30-32,39) indicating that
these methods can be used to make reasonable predictions. By running multiple simulations
in the same nasal cavity model, we demonstrate that the variations in deposition patterns
between simulations were marginal. In addition, with the aid of a statistical power analysis,
we determined an appropriate number of simulations to ensure that our study was adequately
powered.
Previous studies investigating the influence of head position on effectiveness of topical nasal
medications have produced mixed conclusions. Merkus and colleagues(7) suggested that
head position has a substantial influence on the deposition of topical nasal drugs into the
middle meatus. In contrast, other studies found no significant effect of head positions on
drug deposition efficiency.(11,25) As such, the impact of head positions on the efficacy of
intranasal drugs has not been conclusively determined.(33) Our CFD simulations indicate
that particle transport and distribution were not sensitive to head position when inspiratory
airflow was present but were highly sensitive to head position when inspiratory flow was
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absent. With no airflow present, the Mygind position afforded the best penetration, followed
by head back and upright positions, respectively.
The significance of the present study cannot be overlooked given that the prevalence of
septal deviation in healthy adults is between 19.5-26%.(14) Allergic rhinitis and chronic
rhinosinusitis, two conditions frequently treated with topical intranasal medications, are
common conditions in the general population as well, making it likely that many patients
have co-existing anatomic and allergric/inflammatory components contributing to nasal
obstruction. In this population of patients, if a septal deviation or other anatomic deformity
inhibits delivery of topical medication to the areas of the nasal cavity where it will have its
greatest effect surgical correction of an underlying anatomic deformity may greatly increase
the efficacy of medical management.
There are limitations of this preliminary study that warrant mentioning. First, while this
study exposed and quantified the adverse effects of a moderate to severe septal deviation on
INS sprays, our airflow simulations were limited to laminar, steady-state conditions,
meaning that turbulence and the cyclic nature of airflow were not modeled. Second, the
results reflect the nasal anatomy of a single subject with some evidence of nasal cycling
which this preliminary study did not account for. The extent to which mucosal edema
resulting from the nasal cycle may play a role in the distribution of nasal medications is
unclear. In conclusion, CFD simulations suggest that the impact of septal deviation on
intranasal drug delivery was statistically significant. Effective topical drug delivery
technique would ideally incorporate standardized patient instructions as to head position and
appropriate inspiration and take into account the effect of anatomic deformities on drug
deposition.
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Coronal view showing leftward septal deviation. This diagram is reproduced with
permission from Frank et al.(3)
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Aerosol particle deposition posterior of the nasal valve area on the right and left (obstructed)
sides of the airway. The bars indicate the means + standard deviation.
(A) Airflow Present.
(B) Airflow Absent.
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Simulated spray particle deposition pattern on the lateral wall. Particles colored in white
deposited in the anterior region, while the black particles penetrated past the nasal valve
area.
(A) Left (Septal Deviation) side with inspiratory airflow present in the “head upright
position”.
(B) Right side with inspiratory airflow present in the “head upright position”.
(C) Left (Septal Deviation) side with inspiratory airflow absent in the “head upright
position”.
(D) Right side with inspiratory airflow absent in the “head upright position”
(E) Left (Septal Deviation) side with inspiratory airflow absent in the Mygind’s head
position.
(F) Right side with inspiratory airflow absent in the Mygind’s head position.
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Table 2
Testing the null hypothesis that spray particle penetrations past nasal valve for both sides of the nasal cavity
are equal (Hypothesis #1).
Head Position Airflow Left Side (n=5) Right side(n=5) P-value
Upright Present 62.6 ± 7.96 223.0 ± 8.97 <0.00001
Absent 15.2 ± 2.05 72.0 ± 6.44 0.00001
Head Back Present 62.2 ± 7.79 220.0 ± 10.51 <0.00001
Absent 29.0 ± 1.22 109.6 ± 10.01 0.00005
Mygind’s Present 61.6 ± 7.77 219.2 ± 10.03 <0.00001
Absent 105.6 ± 9.5 130.4 ± 9.99 0.00385
The values were presented as means ± standard deviation and were compared with the Student’s t-test. P-value<0.05 indicate statistical significance
(all cases).
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Table 3
Testing the null hypothesis that the presence or absence of inspiratory airflow does not improve efficacy of
particle transport within the nasal cavity (Hypothesis #2).
Head Position Side Flow (n=5) No flow (n=5) P-value
Upright Left (Affected) 62.6 ± 7.96 15.2 ± 2.05 0.00010
Right 223.0 ± 8.97 72.0 ± 6.44 <0.00001
Head Back Left (Affected) 62.2 ± 7.79 29.0 ± 1.22 0.00056
Right 220.0 ± 10.51 109.6 ± 10.01 <0.00001
Mygind’s Left (Affected) 61.6 ± 7.77 105.6 ± 9.5 0.00005
Right 219.2 ± 10.03 130.4 ± 9.99 <0.00001
The values were presented as means ± standard deviation and were compared with the Student’s t-test. P-value<0.05 indicate statistical significance
(all cases).
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Table 4
Testing the null hypothesis that head position does not impact spray particle deposition beyond the anterior
region of the nose (Hypothesis #3). The different head positions were compared using analysis of variance
(ANOVA).
Airflow Side P-value
Present Left (Affected) 0.97963
Right 0.81635
Absent Left (Affected) <0.00001
Right <0.00001
P-value<0.05 indicate statistical significance (all cases).
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